Review and Interpretation of the 2025 ASCO Review

Saturday, July 12, 2025, 8:00 AM - 2:30 PM,  Marriott Indianapolis, Indinaapolis, IN


This program will provide the participants with the latest information available as presented at the 2025 American Society of Clinical Oncology (ASCO) meeting. Hematology/Oncology faculty members from the Indiana University School of Medicine will provide participants with analysis of the more clinically applicable presentations at this year's ASCO meeting.

1. Recall and describe the newest developments in the treatment of breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, head/neck cancer, melanoma, hematological mallignancies.
2. Integrate multimodality treatment strategies, including radiation therapy, chemotherapy, immunotherapy, and targeted therapy, into the management of patients with cancer.
3. Based on the most up-to-date treatments described in the learning sessions, apply new knowledge and strategies about therapies of solid tumors and hematological malignancies into their clinical practice.

Registration opens: April 1, 2025 at 10 AM EST

All educational events will be held at the Marriott Indianapolis Downtown

 

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

AMA PRA Category 1 Credits™ (5.25 hours), ABIM MOC Part 2 (5.25 hours), ABS CC (5.25 hours), ACPE Contact Hours (5.25 hours), ANCC Contact Hours (5.25 hours), Non-Physician Attendance (5.25 hours), Social Work Category I CEU (5.25 hours)

Guest wanting to stay at the Marriott Indianapolis Downtown can use the link below to book a room at the conference rate: https://book.passkey.com/go/IUASCO25

Rates expire 6.20.25

Mitigation of Relevant Financial Relationships

Indiana University School of Medicine, Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Exhibit at this Event